BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 37724895)

  • 1. Oral Probiotics, Streptococcus salivarius K12 and M18, Suppress the Release of Volatile Sulfur Compounds and a Virulent Protease from Oral Bacteria: An In-Vitro Study.
    Park JA; Lee GR; Lee JY; Jin BH
    Oral Health Prev Dent; 2023 Aug; 21():259-270. PubMed ID: 37724895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effect of Streptococcus salivarius K12 and M18 on halitosis in vitro.
    Yoo HJ; Jwa SK; Kim DH; Ji YJ
    Clin Exp Dent Res; 2020 Apr; 6(2):207-214. PubMed ID: 32250565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Streptococcus salivarius inhibits immune activation by periodontal disease pathogens.
    MacDonald KW; Chanyi RM; Macklaim JM; Cadieux PA; Reid G; Burton JP
    BMC Oral Health; 2021 May; 21(1):245. PubMed ID: 33962608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A concerted probiotic activity to inhibit periodontitis-associated bacteria.
    Jansen PM; Abdelbary MMH; Conrads G
    PLoS One; 2021; 16(3):e0248308. PubMed ID: 33667279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lyophilized cell-free supernatants of the oral probiotics Streptococcus salivarius M18 and Streptococcus salivarius K12 show promises for milk safety.
    Karaçam S; Tunçer S
    Lett Appl Microbiol; 2023 Jan; 76(1):. PubMed ID: 36688767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial effect of probiotic bacteriocins on
    Reichardt E; Shyp V; Alig L; Verna C; Kulik EM; Bornstein MM
    J Oral Microbiol; 2024; 16(1):2304971. PubMed ID: 38288293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of malodorous gas formation by oral bacteria with cetylpyridinium and zinc chloride.
    Kang JH; Kim DJ; Choi BK; Park JW
    Arch Oral Biol; 2017 Dec; 84():133-138. PubMed ID: 28987726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety assessment of
    Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
    Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters.
    Burton JP; Chilcott CN; Moore CJ; Speiser G; Tagg JR
    J Appl Microbiol; 2006 Apr; 100(4):754-64. PubMed ID: 16553730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Streptococcus thermophilus on volatile sulfur compounds produced by Porphyromonas gingivalis.
    Lee SH; Baek DH
    Arch Oral Biol; 2014 Nov; 59(11):1205-10. PubMed ID: 25105253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial activity of Streptococcus salivarius K12 on bacteria involved in oral malodour.
    Masdea L; Kulik EM; Hauser-Gerspach I; Ramseier AM; Filippi A; Waltimo T
    Arch Oral Biol; 2012 Aug; 57(8):1041-7. PubMed ID: 22405584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Effect of Streptococcus salivarius K12 on Halitosis: a Double-Blind, Randomized, Placebo-Controlled Trial.
    He L; Yang H; Chen Z; Ouyang X
    Probiotics Antimicrob Proteins; 2020 Dec; 12(4):1321-1329. PubMed ID: 32227309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
    Chen TY; Hale JDF; Tagg JR; Jain R; Voss AL; Mills N; Best EJ; Stevenson DS; Bird PA; Walls T
    Probiotics Antimicrob Proteins; 2021 Jun; 13(3):734-738. PubMed ID: 33179212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploiting the Acidic Extracellular pH: Evaluation of Streptococcus salivarius M18 Postbiotics to Target Cancer Cells.
    Karaçam S; Tunçer S
    Probiotics Antimicrob Proteins; 2022 Dec; 14(6):995-1011. PubMed ID: 34080175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-free supernatant of Streptococcus salivarius M18 impairs the pathogenic properties of Pseudomonas aeruginosa and Klebsiella pneumonia.
    Tunçer S; Karaçam S
    Arch Microbiol; 2020 Dec; 202(10):2825-2840. PubMed ID: 32747998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon Gamma Response in Human Saliva Following Exposure to the Oral Probiotic Streptococcus salivarius BLIS K12.
    Laws GA; Harold LK; Tagg JR; Hale JDF
    Probiotics Antimicrob Proteins; 2024 Feb; 16(1):93-98. PubMed ID: 36477439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review.
    Zupancic K; Kriksic V; Kovacevic I; Kovacevic D
    Probiotics Antimicrob Proteins; 2017 Jun; 9(2):102-110. PubMed ID: 28236205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Volatile sulfide compounds and oral microorganisms on the inner surface of masks in individuals with halitosis during COVID-19 pandemic.
    Lee YH; Kim H; Heo DW; Ahn IS; Auh QS
    Sci Rep; 2023 Feb; 13(1):2487. PubMed ID: 36781937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Probiotic Streptococcus salivarius K12 and M18 Lozenges on the Cariogram Parameters of Patients With High Caries Risk: A Randomised Control Trial.
    Poorni S; Nivedhitha MS; Srinivasan M; Balasubramaniam A
    Cureus; 2022 Mar; 14(3):e23282. PubMed ID: 35449617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probiotic
    Wang Y; Li J; Zhang H; Zheng X; Wang J; Jia X; Peng X; Xie Q; Zou J; Zheng L; Li J; Zhou X; Xu X
    Front Immunol; 2021; 12():684824. PubMed ID: 34149727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.